4//SEC Filing
Butchko Julia G. 4
Accession 0001764013-23-000101
CIK 0001764013other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:00 PM ET
Size
7.1 KB
Accession
0001764013-23-000101
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Butchko Julia G.
Chief Dev. & Tech. Officer
Transactions
- Sale
Common Stock
2023-08-24$20.30/sh−12,332$250,340→ 416,261 total - Sale
Common Stock
2023-08-24$20.89/sh−1$21→ 416,260 total
Footnotes (2)
- [F1]On August 17, 2022, the holder was granted 112,816 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on August 17, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.87 - $20.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001796290
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 5:00 PM ET
- Size
- 7.1 KB